http://www.merrimackpharma.com Tue, 14 Feb 2012 18:36:40 +0000 en hourly 1 http://www.merrimackpharma.com/information/phase-1-data-on-mm-398-will-be-presented-at-the-asco-2012-gastrointestinal-cancers-symposium/ http://www.merrimackpharma.com/information/phase-1-data-on-mm-398-will-be-presented-at-the-asco-2012-gastrointestinal-cancers-symposium/#comments Thu, 12 Jan 2012 21:36:39 +0000 merr-ryaroschuk-01 http://www.merrimackpharma.com/?p=418 http://www.merrimackpharma.com/information/phase-1-data-on-mm-398-will-be-presented-at-the-asco-2012-gastrointestinal-cancers-symposium/feed/ 0 http://www.merrimackpharma.com/information/merrimack-pharmaceuticals-initiates-enrollment-in-phase-1-study-of-mm-151-in-patients-with-refractory-advanced-solid-tumors/ http://www.merrimackpharma.com/information/merrimack-pharmaceuticals-initiates-enrollment-in-phase-1-study-of-mm-151-in-patients-with-refractory-advanced-solid-tumors/#comments Wed, 11 Jan 2012 21:31:40 +0000 merr-ryaroschuk-01 http://www.merrimackpharma.com/?p=412 http://www.merrimackpharma.com/information/merrimack-pharmaceuticals-initiates-enrollment-in-phase-1-study-of-mm-151-in-patients-with-refractory-advanced-solid-tumors/feed/ 0 http://www.merrimackpharma.com/information/merrimack-pharmaceuticals-initiates-enrollment-in-a-phase-1-study-of-mm-121-in-combination-with-cetuximab-and-irinotecan-in-patients-with-advanced-cancers/ http://www.merrimackpharma.com/information/merrimack-pharmaceuticals-initiates-enrollment-in-a-phase-1-study-of-mm-121-in-combination-with-cetuximab-and-irinotecan-in-patients-with-advanced-cancers/#comments Tue, 13 Dec 2011 21:08:00 +0000 merr-ryaroschuk-01 http://www.merrimackpharma.com/?p=405 http://www.merrimackpharma.com/information/merrimack-pharmaceuticals-initiates-enrollment-in-a-phase-1-study-of-mm-121-in-combination-with-cetuximab-and-irinotecan-in-patients-with-advanced-cancers/feed/ 0 http://www.merrimackpharma.com/information/merrimack-pharmaceuticals-initiates-enrollment-in-a-phase-1-combination-study-of-mm-121-and-multiple-anticancer-therapies-in-patients-with-advanced-solid-tumors/ http://www.merrimackpharma.com/information/merrimack-pharmaceuticals-initiates-enrollment-in-a-phase-1-combination-study-of-mm-121-and-multiple-anticancer-therapies-in-patients-with-advanced-solid-tumors/#comments Wed, 30 Nov 2011 21:36:20 +0000 merr-ryaroschuk-01 http://www.merrimackpharma.com/?p=401 http://www.merrimackpharma.com/information/merrimack-pharmaceuticals-initiates-enrollment-in-a-phase-1-combination-study-of-mm-121-and-multiple-anticancer-therapies-in-patients-with-advanced-solid-tumors/feed/ 0 http://www.merrimackpharma.com/information/for-immediate-release-merrimack-pharmaceuticals-initiates-enrollment-in-phase-2-study-of-mm-121-in-combination-with-erlotinib-in-three-groups-of-patients-with-non-small-cell-lung-cancer/ http://www.merrimackpharma.com/information/for-immediate-release-merrimack-pharmaceuticals-initiates-enrollment-in-phase-2-study-of-mm-121-in-combination-with-erlotinib-in-three-groups-of-patients-with-non-small-cell-lung-cancer/#comments Fri, 18 Nov 2011 21:21:19 +0000 merr-ryaroschuk-01 http://www.merrimackpharma.com/?p=397 http://www.merrimackpharma.com/information/for-immediate-release-merrimack-pharmaceuticals-initiates-enrollment-in-phase-2-study-of-mm-121-in-combination-with-erlotinib-in-three-groups-of-patients-with-non-small-cell-lung-cancer/feed/ 0 http://www.merrimackpharma.com/information/multiple-programs-from-merrimack-pharmaceuticals%e2%80%99-pipeline-to-be-presented-at-the-2011-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics/ http://www.merrimackpharma.com/information/multiple-programs-from-merrimack-pharmaceuticals%e2%80%99-pipeline-to-be-presented-at-the-2011-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics/#comments Fri, 11 Nov 2011 20:27:44 +0000 merr-ryaroschuk-01 http://www.merrimackpharma.com/?p=390 http://www.merrimackpharma.com/information/multiple-programs-from-merrimack-pharmaceuticals%e2%80%99-pipeline-to-be-presented-at-the-2011-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics/feed/ 0 http://www.merrimackpharma.com/information/merrimack-pharmaceuticals-initiates-enrollment-in-a-neoadjuvant-phase-2-study-of-mm-121-with-paclitaxel-in-her2-negative-breast-cancer-patients/ http://www.merrimackpharma.com/information/merrimack-pharmaceuticals-initiates-enrollment-in-a-neoadjuvant-phase-2-study-of-mm-121-with-paclitaxel-in-her2-negative-breast-cancer-patients/#comments Tue, 11 Oct 2011 13:28:06 +0000 merr-ryaroschuk-01 http://www.merrimackpharma.com/?p=376 http://www.merrimackpharma.com/information/merrimack-pharmaceuticals-initiates-enrollment-in-a-neoadjuvant-phase-2-study-of-mm-121-with-paclitaxel-in-her2-negative-breast-cancer-patients/feed/ 0 http://www.merrimackpharma.com/news/merrimack-pharmaceuticals-initiates-enrollment-in-phase-1-study-of-mm-302-in-her2-positive-breast-cancer-patients/ http://www.merrimackpharma.com/news/merrimack-pharmaceuticals-initiates-enrollment-in-phase-1-study-of-mm-302-in-her2-positive-breast-cancer-patients/#comments Mon, 08 Aug 2011 15:49:07 +0000 mmwebadmin01 http://50.56.88.104/?p=95 http://www.merrimackpharma.com/news/merrimack-pharmaceuticals-initiates-enrollment-in-phase-1-study-of-mm-302-in-her2-positive-breast-cancer-patients/feed/ 0 http://www.merrimackpharma.com/news/fda-grants-orphan-drug-status-to-merrimack-pharmaceuticals%e2%80%99-mm-398-a-nanotherapeutic-encapsulation-of-irinotecan-for-the-treatment-of-pancreatic-cancer/ http://www.merrimackpharma.com/news/fda-grants-orphan-drug-status-to-merrimack-pharmaceuticals%e2%80%99-mm-398-a-nanotherapeutic-encapsulation-of-irinotecan-for-the-treatment-of-pancreatic-cancer/#comments Mon, 01 Aug 2011 19:11:49 +0000 mmwebadmin01 http://50.56.88.104/?p=299 http://www.merrimackpharma.com/news/fda-grants-orphan-drug-status-to-merrimack-pharmaceuticals%e2%80%99-mm-398-a-nanotherapeutic-encapsulation-of-irinotecan-for-the-treatment-of-pancreatic-cancer/feed/ 0 http://www.merrimackpharma.com/news/merrimack-announces-presentation-of-preclinical-data-at-the-14th-world-conference-on-lung-cancer/ http://www.merrimackpharma.com/news/merrimack-announces-presentation-of-preclinical-data-at-the-14th-world-conference-on-lung-cancer/#comments Thu, 30 Jun 2011 19:10:23 +0000 mmwebadmin01 http://50.56.88.104/?p=296 http://www.merrimackpharma.com/news/merrimack-announces-presentation-of-preclinical-data-at-the-14th-world-conference-on-lung-cancer/feed/ 0